|
The ongoing global pandemic has caused complete upheaval across the world for individuals and businesses alike. Within the pharmaceutical and life science industry, the need to develop a vaccine quickly is putting immense pressure on a workforce that is arguably already stretched, as skills shortages continue to have an effect on resources. However, while the pandemic has certainly presented a number of challenges, it has also created opportunities that have the potential to help alleviate many long-standing recruitment barriers.
So, what impact has COVID-19 had on talent acquisition across the life science and pharma industry?
A Changing Talent Landscape
STEM skills shortages have been widely discussed for some time now, and anyone in the pharma or life science arena will certainly be acutely aware of the talent challenges facing almost every firm in the field. The simple truth is that following a career in STEM-related professions doesn’t appeal to enough individuals in education to ensure a steady stream of newly trained recruits to meet demand on a global scale. With digital skills in limited supply, but high demand across almost every sector, attracting tech talent into pharma and the life science industry isn’t easy.
|
.jpg)
